Aletho News

ΑΛΗΘΩΣ

Pfizer Document Dump Shows Doctor With Ties to Gates Foundation Deleted Trial Participant’s Vaccine Injury

By Michael Nevradakis, Ph.D. | The Defender | May 18, 2022

An 80,000-page cache of Pfizer-BioNTech COVID-19 vaccine documents released by the U.S. Food and Drug Administration (FDA) sheds light on Pfizer’s extensive vaccine trials in Argentina, including the unusually large size of the trials and the story of a trial participant whose vaccine reaction was “disappeared.”

The case of Augusto Roux in Argentina suggests that in at least one instance, a trial participant whose symptoms were determined to be connected to the COVID-19 vaccine was later listed, in official records, as having experienced adverse events that were not related to the vaccination.

Vaccine trials in Argentina also appear to have glossed over adverse events suffered by other trial participants, and the potential connection between the adverse events and the vaccine.

The FDA on May 2 released the latest cache of documents, which pertain to the Emergency Use Authorization of Pfizer’s vaccine, as part of a court-ordered disclosure schedule stemming from an expedited Freedom of Information Act request filed in August 2021.

As previously reported by The Defender, the documents included Case Report Forms from Pfizer COVID vaccine trials in the U.S., and the “third interim report” from BioNTech’s trials conducted in Germany, both of which listed adverse events sustained by participants in the U.S. and German trials.

Many of these adverse events were indicated as being “unrelated” to the vaccines — even in instances where the patients were healthy or otherwise had no prior medical history related to the injuries they sustained.

Story of ‘disappeared patient’ goes public

Several bloggers and online investigators called into question various aspects of the Argentine vaccine trials, pointing out the number of participants in the Argentine trials dwarfed that of other, typically smaller trials at other locations in different countries.

They also pointed out the large number of participants appeared to have been recruited to the trial in a remarkably short time, and questioned the connections between one of the key figures of the Argentine trial to vaccine manufacturers, Big Pharma and the Bill & Melinda Gates Foundation.

The large number of trial participants in Argentina may be related to the fact that the trial appears to have been held simultaneously in 26 hospitals.

The large number of participants is revealed in another of the documents released this month, where on page 2,245, the list of randomized participants at trial site 1231 begins, while on page 4,329, the list of participants at trial site 4444 begins.

Site 1231 refers to the main trial site location and 4444 (page 24) most likely refers to the disparate hospitals participating in the trial outside the main location.

Commenting on the revelation, blogger David Healy wrote:

“About 5,800 volunteers were enrolled, half getting the active vaccine. This is almost 4 times more than the next largest centre in this trial.

“Amazingly 467 doctors were almost instantly signed up and trained as assistant investigators in the study.”

In all, 4,501 patients participated in the Argentine trials, representing 10% of all Pfizer trial participants worldwide.

Complete information about adverse events during this extensive trial in Argentina does not appear to have been released as of this writing.

However, Roux’s experience has since become public.

Roux, often referred to as the “disappeared” patient, volunteered for the trial (volunteer number 12312982) and received his first dose of the Pfizer vaccine on Aug. 21, 2020.

According to Healy, Roux “felt pain and swelling in his arm right after the injection. Later that day he had nausea, difficulty swallowing, and felt hungover.”

After a series of symptoms, Roux — during a clinical trial visit on Aug. 23, 2020 — was classified as experiencing a “toxicity grade 1 adverse effect.”

He nevertheless received his second dose on Sept. 9, 2020.

According to Healy:

“On the way home by taxi, he started feeling unwell. At 19:30, he was short of breath, had a burning pain in his chest and was extremely fatigued. He lay on his bed and fell asleep. He woke up at 21:00 with nausea and fever (38-39 C) and was unable to get out of bed due to the fatigue.

“Over the next two days, he reports a high fever (41 C) and feeling delirious.

“On September 11, he was able to get out of bed and go to the bathroom when he observed his urine to be dark (like Coca-Cola). He felt as if his heart expanded, had a sudden lack of breath and fell unconscious on the floor for approximately 3 hours.

“Once he recovered, he felt tired, was uncomfortable, had a high heart rate on minor movement, was dizzy when changing posture. He had a chest pain which radiated to his left arm and back.”

On Sept. 12, 2020, Roux was admitted to the Hospital Alemán, where he stayed for two days. It was initially believed he had COVID-19, but he tested negative for the virus. His symptoms also were found to not correspond with viral pneumonia.

After a series of X-rays, CT scans and urine tests, Roux was discharged Sept. 14, 2020, after being diagnosed with an adverse reaction — specifically, an unequivocal pericardial effusion — to the coronavirus vaccine (high probability), according to his discharge summary.

Doctor who altered Roux’s record had ties to Gates, NIH, Big Pharma

However, on Sept. 17, Dr. Fernando Polack, Pfizer’s lead investigator for the Argentine trials according to a Pfizer document released in December 2021, reported in Roux’s record that his “hospitalization was not related to the vaccine.”

Even after Roux’s discharge, his health difficulties continued. As reported by Healy:

“On November 13 [2020], he had negative IgG and IgM SARS COV-2 (QML technique), which is unusual post vaccine.

“On February 24, 2021, a liver scan showed a minor degree of abnormality. In March 2021 and February 2022, his liver enzymes remained abnormal.”

Ultimately, Roux lost 14 kilograms (30.8 pounds) in a period of three to four months, and continued to suffer from fever and bouts of breathlessness for several months afterward.

Polack, who reported Roux’s hospitalization as unrelated to the vaccination, is known for his close ties with various vaccine manufacturers, pharmaceutical companies and the Bill & Melinda Gates Foundation.

For instance, he is listed as the lead author in a Dec. 31, 2020, New England Journal of Medicine (NEJM) article on the purported efficacy of the Pfizer COVID-19 vaccine.

According to Healy, Polack also appears to be the founder of iTRIALS, a trial site management company, and another organization located at the same physical headquarters, the Fundación INFANT.

Healy wrote:

“When COVID struck Argentina, [Polack] and his Fundación became involved in a trial of immune plasma, taken from patients who had recovered from COVID, given to patients who had recently acquired the disease.

“In May 2020 he speculated that this would make COVID like an ordinary cold, and the Gates Foundation would offer financial support. He used high-profile press conferences to disseminate his exciting message.”

The conclusion of the study published in the NEJM following the plasma study reads:

“Funded by the Bill and Melinda Gates Foundation and the Fundación INFANT Pandemic Fund; Dirección de Sangre y Medicina Transfusional del Ministerio de Salud number, PAEPCC19, Plataforma de Registro Informatizado de Investigaciones en Salud number, 1421, and ClinicalTrials.gov number, NCT04479163.”

According to Healy, “[a] subsequent systematic review and meta-analysis failed to confirm these findings, noting ‘very serious imprecision concerns.’”

Healy pointed out that Polack, in his NEJM disclosure statement, did not indicate any conflict of interest or financial interest in the COVID-19 vaccine trials in Argentina, but:

“Polack reported grants from Novavax and personal fees from Janssen, Bavarian Nordic A/S, Pfizer, Sanofi, Regeneron, Merck, Medimmune, Vir Bio[technology], Ark Bio, Daiichi Sankyo outside the submitted work.

“At least eight of these companies are engaged in RSV vaccine research in babies and pregnant women. Fernando has mentioned a combined RSV, flu and COVID vaccine.”

And, in relation to Polack’s relationship with the Bill & Melinda Gates Foundation, Healy reported:

“[Polack] also doesn’t mention his extensive financial involvement with the Bill & Melinda Gates Foundation. This organization supports industry vaccine trials including Covid and RSV. Fernando is heavily involved through his Gates-sponsored Fundación INFANT in Buenos Aires in RSV trials and research.

“Gates sunk $82,553,834 into Novavax’s RSV vaccine ResVax which was shown to be ineffective in clinical trials in pregnant women.”

Polack’s own bio from a 2017 medical conference states “[h]is work is funded by the Bill & Melinda Gates Foundation, the National Institutes of Health [NIH], the Thrasher Research Fund, the Optimus Foundation and other international organizations.”

That same year, Polack testified at an FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, where he “acknowledged having financial interests in or professional relationships with some of the affected firms identified for this meeting, namely Janssen [producer of the Johnson & Johnson COVID vaccine], Novavax, and Bavarian Nordic.”

According to Dr. Joseph Mercola, Polack “also happens to be a consultant for the U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC),” and “a current adjunct professor at Vanderbilt University in Tennessee.”

Michael Nevradakis, Ph.D., is an independent journalist and researcher based in Athens, Greece.

May 20, 2022 Posted by | Corruption, Deception, Science and Pseudo-Science | , , , , , , , | 1 Comment

Vaccinators Won’t Stop Vaccinating

By Dr. Joseph Mercola | February 4, 2022

Many experts have sounded the alarm that the COVID-19 pandemic was all about the shot1 and a larger agenda to impose totalitarian control worldwide.2 Already, one shot has turned into two doses and a third booster. A fourth booster is also being discussed, including by Moderna CEO Stéphane Bancel, who said that the efficacy of the third shot is likely to decline over several months, necessitating another shot soon thereafter.3

“I will be surprised when we get that data in the coming weeks that it’s holding nicely over time — I would expect that it’s not going to hold great,” Bancel said in an interview with Goldman Sachs.4 Conveniently, Moderna is working on an Omicron-specific jab that they hope to release as early as March 20225 — and this is only the beginning.

Writing on Substack, contributor Eugyppius explained, “Moderna, just one of multiple pharmaceuticals eager to exploit our new vaccine mania, are expanding their manufacturing capacity to produce as many as 6 billion mRNA vaccine doses per year.”6 The information came straight from the horse’s mouth, at a virtual meeting held the first day of the World Economic Forum’s (WEF) Davos Agenda 2022, at a session titled “COVID-19: What’s Next?”7

Along with Bancel, the meeting was attended by Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID), Richard Hatchett, CEO of the Coalition for Epidemic Preparedness Innovations (CEPI), and professor Annelies Wilder-Smith from the London School of Hygiene and Tropical Medicine, who together detailed their plans for “vaccine mania” to persist indefinitely.

Combined Shots Planned to Avoid ‘Compliance Issues’

During the discussion, Bancel states that Moderna is actively preparing for “what should the vaccine be in the fall of 2022, and what should it contain.” The company is “working with public health experts like Fauci’s team to figure this out. Because soon we’re going to have to decide what goes into the vaccine for fall of 2022,” he said.8

Fauci’s NIAID is part of the U.S. National Institutes of Health (NIH), which, some may be surprised to learn, actually owns half the patent for Moderna’s COVID-19 injection. In fact, the NIH owns thousands of pharmaceutical patents, and the U.S. Centers for Disease Control and Prevention spends $4.9 billion a year out of its $12 billion budget buying and distributing vaccines.

“Tony Fauci was able to choose, to designate, four of his high-level employees who each get individual patent shares,” according to Robert F. Kennedy Jr. in an interview with James Corbett.9 “They will collect $150,000 a year for life if the Moderna vaccine is approved, which it has been.”10

In addition to working closely with Fauci, Moderna is planning to combine multiple shots, such as a COVID-19 shot, a flu shot and a respiratory syncytial virus (RSV) shot, into one injection — coming in 2023 — to help avoid “compliance issues.” He said:11

“The other piece we’re working on is for 2023, is how do we make it possible from a societal standpoint that people want to be vaccinated?

And we’re going to do this by preparing combinations, we’re working on the flu vaccine, we’re working on an RSV vaccine, and our goal is to be able to have a single annual booster, so that we don’t have compliance issues, where people don’t want to get two to three shots a winter, but they get one dose, where they get a booster for corona, and a booster for flu and RSV, to make sure that people get their vaccine.”

When asked how soon this would occur, he continued:12,13

“So the RSV program is now in Phase 3, the flu program is in Phase 2 and soon in Phase 3, I hope as soon as second quarter of this year. So the best case scenario would be the fall of 2023, as a best case scenario, I don’t think it would [be available] in every country, but we believe it’s possible to operate in some countries next year.”

Vaccines for at Least 20 Pathogens in the Works

SARS-Cov-2 isn’t the only virus that Moderna and other pharmaceutical companies, along with health officials, are intent on targeting with more shots. Remember zika virus, which Kennedy described as another pandemic fabricated for the purpose of selling pharmaceuticals and advancing totalitarian control?14 There’s a vaccine on the way.

How about Nipah virus? Nipah virus, a zoonotic pathogen for which no treatments exist, is the inspiration for the film “Contagion.”15 The virus can only be experimented on in BSL-4 laboratories. As an aside, the National Bio and Agro-Defence Facility in Kansas will be the first biocontainment facility16 in the U.S. where research on Nipah (and Ebola) can be conducted on livestock.

In 2019, Nipah Malaysia was also among the deadly virus strains shipped17 from Canada’s National Microbiology Lab to the Wuhan Institute of Virology. If you haven’t heard of Nipah yet, you likely will soon — another vaccine is in the works for it. Bancel said:18,19

“We’re working with Dr. Fauci’s team, we’re working with Richard [Hatchett], to work on many more pathogens … The entire scientific community has known for years that there’s at least around 20-ish pathogens that are a risk for which we need vaccines, you know we have zika vaccine in Phase 2 … we’re working on a Nipah vaccine, those are viruses that not everybody has heard of.

Because we need to have the data. What dose, what construct from a genetic standpoint is required … so that if a new pathogen emerges from that family we can very quickly move into a Phase 3.”

More mRNA Shots Are Coming

Many other vaccines are also under development, including a Phase 3 study looking at combining Pfizer’s COVID-19 injection with their Prevnar 20™ (pneumococcal 20-valent conjugate vaccine) for adults aged 65 and older.20

In a related news release, Kathrin U. Jansen, Ph.D., senior vice president and head of vaccine research and development at Pfizer spoke about the importance of “raising awareness of the importance of adult” vaccinations, echoing Bancel in their desire to create combination shots so adults can get multiple vaccines at one doctor or pharmacy visit.

“As the COVID-19 vaccines and booster doses continue to be administered, we believe that health care providers have an opportunity to talk to their adult patients about other recommended vaccines in line with CDC guidance,” she said.21

An agreement between Pfizer and BioNTech to develop the first mRNA shingles vaccine was also reached in January 2022.22 According to a Pfizer news release, “While there are currently approved vaccines for shingles, there is an opportunity to develop an improved vaccine that potentially shows high efficacy and better tolerability, and is more efficient to produce globally, by utilizing mRNA technology.”23

A Phase 1 study by Moderna for its mRNA Epstein-Barr virus shot is also underway. The first dose of the experimental shot was given to a study subject January 5, 2022,. In a news release, Moderna detailed their intent on rolling out additional mRNA vaccines against a number of additional viruses as well:24

“The start of this Phase 1 study is a significant milestone as we continue to advance mRNA vaccines against latent viruses, which remain in the body for life after infection and can lead to chronic medical conditions. Moderna is committed to developing a portfolio of first-in-class vaccines against latent viruses for which there are no approved vaccines today, including vaccines against CMV [cytomegalovirus], EBV and HIV.

Our research team is working to bring even more vaccines against latent viruses to the clinic. We believe these vaccines could have a profound impact on quality of health for hundreds of millions of people around the world.”

Other mRNA shots also in development include:

  • An mRNA cancer vaccine for non-small cell lung cancer (NSCLC)25
  • mRNA influenza shots, which are under development by several companies, including Pfizer, Moderna, Sanofi and Translate Bio26
  • An mRNA HIV vaccine, one of which is being studied by Moderna in collaboration with the NIH27
  • Various additional mRNA cancer vaccines, including one targeting advanced melanoma — being developed by BioNTech and Regeneron Pharmaceuticals28 — and several being developed by Moderna, targeting melanoma, NSCLC, colorectal cancer and pancreatic cancer29

Ramping Up Production for Billions of Doses

In case there were any doubt that the powers that be intend to use injections as an increasingly integral part of your health care routine and daily life, Bancel described plans for billions of doses of shots to be manufactured in a matter of months. He said during the WEF session:30,31

“The other piece is manufacturing. If you look in 2020, we were able to ship 20 million doses to the U.S. government when the vaccine was authorized. That is not a lot.

But this year we’re going to have 2 to 3 billion doses of capacity in a six-month timeframe, which is what I believe it will take us to get authorization of a vaccine, if all the work has been done before … you could have 1.5 billion doses available in six months, and that’s just from Moderna. And you have other platforms, it could be a much bigger number …”

With censorship now so pervasive, and Big Tech colluding with dictators and pharmaceutical companies to bury the harms occurring through these experimental vaccines — including death — it’s now more important than ever to let your voice be heard in support of medical freedom and opposition of government health officials intimidating, threatening and coercing citizens to violate their conscientiously-held beliefs.

The ethical principal of informed consent to medical risk taking, which includes the legal right to make voluntary decisions about getting experimental injections, must be protected. For now, however, as Eugyppius explained:32

“The vaccinators are a great sword of Damocles over our heads. As I type this, they are scouring the earth for the novel pathogens their products require, and they, together with their bureaucratic and academic allies, will do their level best to call into being new pandemic scares and vaccination campaigns whenever possible — perhaps every flu season.”

Sources and References

February 5, 2022 Posted by | Science and Pseudo-Science, Timeless or most popular | , , , , , | 1 Comment

Universal Vaccinations for Children will be Overseen by Committee which Accepts Vaccine Manufacturer Monies

By Janet Phelan – New Eastern Outlook – 10.12.2015

A House of Representatives Bill, short titled “Vaccinate All Children Act of 2015,” has been referred to the Subcommittee on Health and is awaiting committee action.

HR  2232 was introduced by Frederica Wilson, Democrat from Florida and is largely modeled on the California student vaccination act, which was signed into law by Governor Jerry Brown in June of this year.

Like the California Act, HR 2232 removes all previous exemptions from vaccination, other than a medical exemption, supported by a medical doctor’s statement that a particular vaccination would be hazardous to a specific child’s well- being. Gone are the religious exemptions and philosophical exemptions.

Previously, forty-eight states had laws on the books honoring religious exemptions and nineteen states allowed philosophical exemptions.

This Act would override any state law governing vaccine exemptions, making it mandatory for all students at public elementary and secondary schools to be vaccinated. The bill would amend the Public Health Services Act to require students “to be vaccinated in accordance with the recommendations of the Advisory Committee on Immunization Practices.” (ACIP)

The bill does not, however, reveal which vaccinations would be mandatory nor does it place a cap on vaccinations.

The above cited Advisory Committee, which will be making the decisions concerning which shots are mandatory, is stacked with pro-vaccination heavyweights. Notable committee members include a Dr. Kelly Moore, Director, Tennessee Immunization Program, Dr. Edward Belongia, Director, Center for Clinical Epidemiology & Population Health at the Marshfield Clinic Research Foundation  and Dr. Kathleen Harriman, Chief, Vaccine Preventable Disease Epidemiology Section with the California Department of Public Health, to name a few. Also sitting on the Committee as Ex Officio members are Department of Defense (DoD) officials as well as FDA officials and members of the Department of Veterans Affairs, among representatives from other federal agencies.

Dollars for Docs

A close scrutiny of this Advisory Committee reveals that quite a number of its members are enriching themselves through vaccine industry “donations” or grants.

For example, some of these individuals have a history which includes industry sponsorship or employment. An example is Dr. Belongia, who has been listed as Co-Principal Investigator for an industry sponsored study of effectiveness of quadrivalent influenza vaccine in children.

According to Propublica, a number of these vaccine experts on the Advisory Committee are accepting large sums of vaccine company money. Dr. Gregory Poland, who is with the American College of Physicians and also the Mayo Clinic, has received a total of $17,351.00 from vaccine manufacturers Novartis Vaccines and Sanofi Pasteur. The money changed hands, according to Propublica, for activities by Dr. Poland listed as promotional speaking, consulting and travel and food expenses from November 2013 through December 2014.

Dr. Stanley Grogg, a “Liaison Member” of the Committee and with American Osteopathic Association (AOA), was rewarded for his “promotional speaking” activities, as well as “consulting,” “travel and lodging” and of course the ubiquitous “food and beverage” — to the tune of  $60,391.00. These payments were made during the period of August 2013 through December 2014 and came from a buffet of pharmaceutical companies, including Pfizer, Sanofi, Novartis Vaccines and GlaxoSmithKline, among others.

Dr. Kenneth Schmader is listed as a “Liaison Member” of the ACIP, due to his position with the American Geriatrics Society (AGS). He is a Professor of Medicine-Geriatrics and Geriatrics Division Chief at Duke University and Durham VA Medical Centers in Durham, NC. Dr. Schmader received $75,913.79 for research, paid by Merck, Sharp and Dohme Corporation during the program year 2014.

Dr. Carol Baker, a “Liaison member” and with Infectious Diseases Society of America (IDSA) , also works as a Professor of Pediatrics with the Baylor College of Medicine in Houston, Texas. Dr. Baker was also found to have received $37,514.00 from August 2013-December 2014 for speaking, consulting, lodging and eating. The usual suspects pop up as the vaccine manufacturers who contributed to Dr. Baker—Novartis and Pfizer making the majority of the contributions.

Not to be left in the dust, Dr. William Schaffner, a “Liaison Member” from the National Foundation for Infectious Diseases (NFID) and the Chairman, Department of Preventive Medicine, Vanderbilt University School of Medicine, received a total payment of $26,208 in the two year period from Pfizer and Sanofi Pasteur. The total paid Dr. Schaffner for travel and lodging came to $13,653.00.

Committee member Dr. Ruth Karron, who is listed as  Professor and Director at the Center for Immunization Research, Department of International Health at Johns Hopkins Bloomberg School of Public Health in Baltimore, received $ $7,173 from GlaxoSmithKline for consulting from April-December, 2009, while Dr. Lee Harrison of Pittsburgh was paid a total of $27,663.00 by Glaxo and Pfizer, from 2009-2012.

Besides direct payments to pro- vaccine committee members from the pharmaceutical companies, there are other revenue streams gracing ACIP committee members. While this reporter did not find evidence that Advisory Committee member Dr. Arthur Reingold had received the above types of monies from Big Pharma, his name surfaced in connection with an effort to shut down a Professor whose work challenged the conventional wisdom that AIDS was mortally impacting large numbers of Africans. Reingold was assigned to “investigate” professor Peter Duesberg for “misconduct,” surrounding Duesberg’s findings that figures on AIDS deaths in Africa had been deliberately inflated.

As it turned out, Dr. Arthur Reingold had received over $37 million for AIDS research since 1988. Professor Duesberg was subsequently exonerated of the charges.

Dr. David Stephens, a voting member of the Committee, also did not show up on the Propublica list of doctors who took money from pharmaceutical companies. Stephens, whose bio states he has “led research initiatives in the School of Medicine” (at Emory University), is responsible for Emory researchers receiving “$521.8 million from eternal funding agencies in fiscal year 2014.” 

Stephens also hobnobs with the Vaccine Dinner Club, which exists to “advance the practice of vaccine science by stimulating the intellectual potential and research productivity of the vaccine research community in the Southeast…”

Dinners and membership in the club are free, sponsored by Emory University and other organizations. I guess with a half billion dollars knocking around in your pocket, a free lunch for your fellow scientists wouldn’t be much of an issue.

Stephens also sits on the Board of Directors for Georgia Bio, a non-profit organization dedicated to advancing the growth of Georgia’s life sciences industry. Also represented on the Georgia Bio Board are vaccine manufacturers and pharmaceutical companies: Johnson and Johnson, Geovax, Arbor Pharmaceuticals, Immucor, Osmotica Pharmaceutical Company and Femasys.

Georgia Bio was contacted by this reporter, who wished to query what, if any, compensation Stephens received for his service on the Board. Jennifer Kauffman, Development Director, promptly hung up rather than answer.

Should HR 2232 be approved by the US Congress, it is this Advisory Committee which will decide which vaccinations American children must receive. The clear conflict of interest inherent in Committee members padding their wallets with money from the pharmaceutical industry realistically should disqualify the members from making these critical decisions.

Opaque Government

These conflicts of interest are not new for the ACIP. As reported over fifteen years ago by the National Vaccine Information Center,  previous conflicts of interest ranged from  the ACIP chairman owning stock in vaccine giant Merck, to other financial ties between committee members and  vaccine companies. In addition, the National Vaccine Information Center reported that the mandated financial disclosures filed by committee members were incomplete, rendering a full accounting of their financial relationships with pharmaceutical companies difficult, if not impossible.

Regarding the compensation paid by the CDC to ACIP members, CDC reports that;“Appointments are not remunerated. However, members are compensated for expenses incurred by attendance at meetings. Such compensation, which includes the issuance of airline tickets, per diem to cover lodging, meals and incidental expenses will be in accordance with DHHS/CDC travel rules. An optional honorarium of $250/day for each day that a member attends an ACIP meeting is offered to voting members, who are designated as Special Government Employees during their tenure on the Committee.” 

Radio show host (Wise Women Media) Anita Stewart contributed research to this report. This reporter requested that Stewart contact the CDC to query what sort of compensation the ACIP members received, as the CDC will no longer respond to public records or media requests from this reporter. This blacklisting took place following the publication of an article in Activist Post, indicating that the CDC was deflating the numbers of biological weapons labs.

Stewart, who located the above information on ACIP compensation online, was questioned by CDC media officer Sonny Dill, who kept insisting that Stewart was I. Dill also wanted to know who Stewart worked for, stating this information was necessary before answering any questions. Stewart, who was forthcoming in response, reports that Dill declined to supply the information requested.

December 10, 2015 Posted by | Civil Liberties, Corruption, Deception, Science and Pseudo-Science | , , , , , , , , | Leave a comment